Effect of probiotics during vonoprazan‐containing triple therapy on gut microbiota in <i>Helicobacter pylori</i> infection: A randomized controlled trial

202042 citationsJournal Article

Authors

Toshihiko Kakiuchi · Saga University

Akihiko Mizoe

Kentaroh Yamamoto · Yamamoto Hospital

Ichiro Imamura · Imamura Hospital

Kazutoshi Hashiguchi · Imamura Hospital

Hiroharu Kawakubo · Imari Arita Kyoritsu Hospital

Daisuke Yamaguchi · Ureshino Medical Center

Abstract

Biofermin-R combined with VPZ-based therapy resulted in higher microbial α-strain diversity and suppressed stool softening during H pylori eradication therapy.

Topics & Keywords

Helicobacter pylori-related gastroenterology studies Clostridium difficile and Clostridium perfringens research Gastroesophageal reflux and treatments

Publication Details

Published in: Helicobacter

Volume 25, Issue 3, pp. e12690-e12690

DOI: 10.1111/hel.12690

Field-Weighted Citation Impact: 6.47

Command Palette

Effect of probiotics during vonoprazan‐containing triple therapy on gut microbiota in <i>Helicobacter pylori</i> infection: A randomized controlled trial

Authors

Abstract

Topics & Keywords

Publication Details